Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 15 of 16
Inflammation and Treatment of Bacterial Vaginosis Near Term
NCT00720291
Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens Implantation
NCT00366691
Mechanical vs. Alcohol Separation of the Corneal Epithelium During Surface Ablation Refractive Procedures
NCT00366808
Pharmacy Interventions to Improve Chronic Disease Medication Refill
NCT00469365
Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
NCT00408564
The Effect of Contrast Media on Erythrocytes in Healthy Volunteers
NCT00285506
Prometa Protocol for Alcohol Dependence
NCT00262639
Atomoxetine Treatment for ADHD and Marijuana Dependence
NCT00360269
Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1
NCT00218491
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
NCT00268450
Aripiprazole Effects on Alcohol Reactivity and Consumption
NCT00183235
Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
NCT00509665
Determinants of Fetal Inflammatory Exposure at Term
NCT00970151
Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking
NCT00183222
Project Magnify - A Comparison of Two Strategies to Improve Reading Ability
NCT00366392
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
NCT00118196
Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors
NCT00290680
Reduction and Prevention of Seizure Occurrence From Exposure to Auditory Stimulation in Individuals With Neurological Handicaps
NCT01459692
Magnetic Brain Stimulation for the Treatment of Adult Depression
NCT00149838
Transcranial Magnetic Stimulation Effects on Pain Perception
NCT01861574
A Trial of Blunt Needles for the Reduction of Needlestick Injuries During Cesarean Section
NCT00844636
Effects of Behavioral Stress Reduction Programs on Blood Pressure in African American Youth
NCT00241813
Blunt Needles do Not Reduce Needlestick Injuries to Doctors During Suturing After Child-Birth
NCT00536289
Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
NCT00354224
Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders
NCT00438685
Drug Interactions and Bioavailability of Cranberry
NCT00200759
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
NCT00103376
Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
NCT00096304
A Placebo-Controlled Trial of Buspirone for Treatment of Marijuana Dependence
NCT00360191
Improving Quality of Life for African American Female Adolescents With Lupus
NCT00068874
Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1
NCT00149617
Modafinil Combined With Cognitive Behavior Therapy to Treat Cocaine Addiction - 1
NCT00218387
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
NCT00330187
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
NCT00287963
The Effect of Music Periodicity on Interictal Epileptiform Discharges
NCT01515436
Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental Illness
NCT00078741
Evaluation of Vitamin D Requirements During Pregnancy
NCT00292591
Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis
NCT00259857
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
NCT00089102
Mycophenolate for Pulmonary Sarcoidosis
NCT00262132
Gender Differences in Response to Cues in Cocaine Dependence
NCT00969943
Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)
NCT00070954
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
NCT00330239
Timing of Prophylactic Antibiotics for Cesarean Sections
NCT00330278
Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone
NCT00183196
PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
NCT00090870
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
NCT00246441
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
NCT00089128
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
NCT00010439
Alpha-1 Foundation Research Registry
NCT00499941
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medical University of South Carolina pipeline card: 755 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.